chrisvoncsefalvay/vaers-outcomes huggingface dataset:
mild cough; lymph nodes in throat were swollen; achy; fatigue; joint pain; felt horrible; sore throat; nasal congestion; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt horrible), OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (nasal congestion), COUGH (mild cough) and LYMPHADENOPATHY (lymph nodes in throat were swollen) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced FEELING ABNORMAL (felt horrible), OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (nasal congestion), LYMPHADENOPATHY (lymph nodes in throat were swollen), MYALGIA (achy), FATIGUE (fatigue) and ARTHRALGIA (joint pain). On an unknown date, the patient experienced COUGH (mild cough). At the time of the report, FEELING ABNORMAL (felt horrible), OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (nasal congestion), COUGH (mild cough), LYMPHADENOPATHY (lymph nodes in throat were swollen), MYALGIA (achy), FATIGUE (fatigue) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication were provided No concomitant medication were provided.
After two month visit, he started spitting up nearly half his formula after almost every feeding. His sleep habits increased rather than decreasing with age.
Young pregnant woman developed diminished vision bilaterally and headaches 3 wks post Fluzone injection. Reporter will file a complete report after he sees pt. Evaluation incomplete.
Mild tongue tingling approximately 15 minutes s/p vaccination and palpitations with chest pressure approximately 40 minutes s/p vaccination (HR 150-170 x 5 minutes and intermittent PVCs after for approximately 1 hour). No treatment needed, s/s resolved spontaneously approximately 2hrs s/p vaccincation.
Given vaccine dose without added diluent (given 0.2 mL, equivalent to 3x normal dose) with fever, vomiting, and inability to tolerate any liquids since then.
had MMR 3AUG95-to dentist 9AUG95 w/Novocaine inj for fillings x 2; onset of sx 9AUG95 c/o sore throat & inj site discomfort & elevated T w/APAP; c/o stiff neck; 10AUG95 c/o nausea; 11AUG95 c/o diarrhea; seen by MD 11AUG95
Arm Tingling, Arm Hot/Red/Swollen/Palpitation Dizzy + felt Bad -> pt go to ER & Admitted in ICU, HR approximately 200
I have had mild tinnitus for years. It has doubled in volume since getting the vaccine and doesn't seem to be getting any better.
About 2 minutes after the patient received the first dose of the vaccine, she said she felt faint and her face turned pale. Her father and I helped her get to a safe area where she could lie down. Her body went limp and she could not stand or walk. I had her elevate her feet and placed cool ice packs around her neck and face. She did not fully lose consciousness and still had her eyes open and was talking. She did not have any symptoms of anaphylaxis. I had her lie there and sip on water for 30 m,inutes and the patient was able to walk away. I checked in on her in an hour and she was still fine.
Post vax the patient complained of dizziness, disorientation, vomiting and headache. This was followed by difficulty breathing, hot and cold spells and wheezing. Patient was seen in the ER and treated with Benadryl, Zantac, Zyrtec, and Albuterol inhaler. Patient began to recover.
Systemic: Fainting / Unresponsive-Mild, Additional Details: recovered quickly from fainting. ems was called and checked her out. she was able to go home with no continued problems
Shoulder pain radiating down the arm from injection site. My arm does not work like it should. I can't sleep because of the pain. I have tried Ibuprofen 800 mg and tried sulindac 200 mg. Does very little.
per death certificate, pt died at a local HCF with condition contributing to death as COVID 19
shingles; This initial spontaneous report was received from a lawyer on 08-JUN-2020, regarding a case in litigation and refers to a patient of unknown age and gender. The patient's pertinent medical condition, medical history or concurrent conditions were not reported. On or about 19-JUL-2012, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (the dosage regimen information was not reported) for the long-term prevention of shingles and/or zoster-related conditions. Subsequently, on an unspecified date, the patient was treated by a healthcare provider for shingles. As a direct and proximate result of vaccination, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future.
Shooting pain down left arm that continued at least 1 week after vaccine.  Still has significant tenderness over left deltoid 1 week after vaccine.  Pain with extension of arm above head and external rotation of shoulder
After the shot, in the waiting area, one guy told me my son got the adult vacine instead of pediatric.
No side effects reported at this time; accidently given PROQUAD and VARlVAX instead of VARlVAX and MMR-II; accidently given PROQUAD and VARlVAX instead of VARlVAX and MMR-II; This spontaneous report was received from a medical assistant referring to a 1 year old patient of unknown gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided.      On 23-AUG-2021, the patient was accidently given measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) 0.5 ml (1 dose, lot # T032149, expiration date 20-MAR-2022) and varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 ml (1 dose, lot # U007471, expiration date 08-MAR-2023), both intramuscularly (IM) for prophylaxis, instead of varicella virus vaccine live (oka/merck) (VARIVAX) and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (wrong product administered and accidental overdose). Therefore, the patient inadvertently received an extra dose of Varicella. No side effects reported at the time of reporting.
pt says she lost her sense of taste, had chills, nausea for 12 hours.  She had fatigue for 24 hours.  Had a headache for 36 hours. pt says all of her symptoms have subsided.
2/12/13 severe tingling from hips to feet, by the time I got to the hosp. started in my arms. Sent to ICU - symptoms reversed in 48 hrs but very weak - 5 day migraine and vomiting due to intravenous drip. In hosp. 6 days. Couldn't work for 5 wks. Could go to work end of March but only part time. My full time position let me go. Had to look for part time job. Started job beg. of May 2013. Lost 26 lbs. Very weak but grew stronger gradually. Dismissed as a patient from Dr. May 15, 2013.
a little bit of soreness in his arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A 42 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 02Jul2021 (Lot number: EW0217) at the age of 42 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "acid reflux" (unspecified if ongoing), notes: It was so bad it re-activated the acid reflux he had after 16 years of it being gone. There were no concomitant medications. Past drug history included: Prevacid, notes: he was taking Prevacid and like Accutane back in his college days; Accutane, notes: he was taking Prevacid and like Accutane back in his college days.  The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Jul2021, outcome "unknown", described as "a little bit of soreness in his arm".  Additional information: He was very healthy prior to 02Jul2021. Aside from growing up and having minor issues, he was taking Prevacid and like Accutane back in his college days, he was very healthy up until 02Jul2021. When the COVID broke out, he was very healthy. He has never taken any vaccines and or shots other than minor shots when he was young. His dad is a chiropractor and they have never believed in a flu shot. He was a healthy young man other than the fact maybe he was having possible potentially relapses from antibiotics he took years before, but he has never experienced anything like he has experienced after the COVID vaccine. No additional Vaccines Administered on Same Date of the Pfizer Suspect. No prior Vaccinations (within 4 weeks).   Follow-up attempts are completed. No further information is expected.
Patient was given the wrong formulation of Pfizer bivalent booster for patient age; patient was given 0.2mL of Pfizer bivalent (NDC 59267-0304-02) approved for ages 12+. Patient experienced no adverse effects.
FOOT INJURY; POSSIBLE DECREASED IMMUNE RESPONSE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. The batch number is not reported and is requested. No concomitant medications were reported. On 14-MAR-2021, the subject experienced foot injury. On 14-MAR-2021, the subject experienced possible decreased immune response. Treatment medications included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the foot injury and possible decreased immune response was not reported. This report was non-serious.
Headache, Myalgia, Fever, Diarrhea, NauseaVomiting, chills, hot and cold Narrative:
Chills; Body aches; Fever 102.1; headache; felt fatigued; This is a spontaneous report from a non-contactable consumer, the patient . A 27-years old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6207) via an unspecified route of administration in the left arm on 19Mar2021 at 16:45 (at the age of 27-years-old) as a single for COVID-19 immunisation. The patient medical history included gastritis due to H. Pylori. The concomitant medications included Famotidine (UNKNOWN MANUFACTURER),ethinylestradiol, ferrous fumarate, norethisterone acetate (LOESTRIN FE), bifidobacterium infantis (ALIGN), and Iron (UNKNOWN MANUFACTURER); all from unknown date for unspecified indication. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 23Mar2021 at 08:30, the patient experienced headache and felt fatigued throughout the morning and about 16:00, the headache became unbearable and began to have chills and body aches and ended up having a 102.1 fever. The patient underwent lab tests and procedures, which included COVID test(nasal swab) on 24Mar2021 and resulted negative. Therapeutic measures were taken as a result of the events and included treatment herself Tylenol and woke up the next morning fever free and slight body aches which only lasted for a few more hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events body aches, chills, fatigue, unbearable headache and fever was recovered on unknown date.   No follow-up attempts are needed. No further information is expected.
This spontaneous case was reported by a consumer and describes the occurrence of ANGINA PECTORIS (mild symptoms of heart pain) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. In May 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021, the patient experienced ANGINA PECTORIS (mild symptoms of heart pain) (seriousness criterion medically significant). At the time of the report, ANGINA PECTORIS (mild symptoms of heart pain) outcome was unknown. Action taken with mRNA-1273 vaccine due to the event was not applicable. No concomitant medications were reported. No treatment details were provided. Patient got both 1st and 2nd doses of Moderna vaccine in May and since then had mild symptoms of heart pain. Company Comment: Very limited information regarding this event has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding this event has been provided at this time. Further information has been requested.
Shingles on eye/ shingles affecting the right eye; Shingles; Blistery rash; This case was reported by a other health professional via call center representative and described the occurrence of ophthalmic herpes zoster in a 60-year-old male patient who received Herpes zoster (Shingrix) (batch number AP257, expiry date 30th November 2021) for prophylaxis.   On 19th August 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. In August 2019, less than 2 weeks after receiving Shingrix, the patient experienced blistery rash. On 28th August 2019, the patient experienced ophthalmic herpes zoster (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the ophthalmic herpes zoster, shingles and blistery rash were not recovered/not resolved.   It was unknown if the reporter considered the ophthalmic herpes zoster, shingles and blistery rash to be related to Shingrix.  Additional details were provided as follows: This case was reported by the medical assistant. The patient received Shingrix on the right deltoid. On 28th August 2019, 9 days after receiving Shingrix the patient experienced ophthalmic herpes zoster, shingles  The reporter had a consumer that came into the office on 28th August 2019 and was diagnosed with Shingles. The shingles appeared as a blistery rash on the right ear, right side of the neck, and affecting the right eye. The reporter was unwilling to provide any additional details.
Numbness and tingling in hands, muscle weakness, fatigue that started in March have severely progressed since to where use of hands is limited and numbness and tingling is very severe.
Painful left arm (where vaccinated); flu like aches; feeling cold; This is a spontaneous report from a contactable consumer reporting for herself. A 30-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3248), via an unspecified route of administration on 10Feb2021 at single dose in Left arm for COVID-19 immunisation. Medical history included coeliac disease from an unknown date. There were no Allergies to medications, food, or other products. The patient was not Pregnant at the time of vaccination. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3248), on 20Jan2021 at the age of 30-year-old at single dose in Left arm for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced Painful left arm (where vaccinated). She experienced flu like aches the day after vaccination as well as feeling cold on 11Feb2021. Since the vaccination, the patient had not been tested for COVID-19There was no treatment received for the adverse event. The outcome of events was recovered. The events were reported as non-serious.
She started getting a small rash on her face. She went to school the following day and started not feeling good (arm really sore, swelling under her armpit, low grade fever and the rash was getting worse (not horrible but definitely noticeable)).  I took her back to the pharmacy where we got the shot and the lady told us to take some Benedryl and contact our doctor if it got worse.  The Benedryl cleared it up and she was feeling better but it came back the next day so I gave her more Benedryl.  It cleared up but it came back today.
So, I had tachycardia which I noticed it towards the end of January.  I noticed it by my watch.   I did go to the ER on March 13th.  I went for the tachycardia and dehydration.  They did put me on betablocker (Metoprolaw).  I have been on the on that for the last month.  I have been to the cardiologist they cannot find anything to cause it.  My heart just beats very fast, and I take the betablocker to slow it down.  .  All the scans that were taken showed normal, I just have a very high heart rate.
persistent inconsolable crying lasting >3 hr; severe local rxn w/swelling/erythema of thigh & reported discoloration in groin
I had "COVID" arm on my left arm where by the injection that measured 2 1/2 inches by 1 1/2 inches.  It apperead 7 days after injection and lasted almost 3 full days.
pt received his meningitis, polio, influenza and Td vaccinations on the morning of 13 Oct 07. He reported no problems that day. On Sunday, he had his first PT without rolling or twisting his left ankle. He noted pain in his ankle when he tired to stand and he required assistance to return to room. When he got to his room, he noticed swelling on the outside of his left ankle and initially thought it was related to his PT earlier that day. He went to the emergency department in which he had a normal x-ray, and they tried to tap his ankle but did not get any fluid. Other than a low-grade fever, he denied any other symptoms. The swelling had decreased and on Monday morning, he was discharged with a posteror splint and non-weight bearing crutches. On the evening of the 15 he removed the wrap and splint and noticed that his entire foot and ankle was swollen, with decrease range of motion and discomfort. He did not notice swelling or discomfort during the day. He denied swelling above the level of his ankle. He returned to the emergency department Monday evening, in which he also noticed minimal swelling to his rt ankle and a small area of swelling on his rt knee. He was admitted and then on Tuesday morning he had developed spots on the top of his left foot only. He had no recall of fever or other symptoms. He was placed on vancomycin and soon afterwards began to develop redness, itching and hives on his upper body and scalp. The vancomycin was stopped and he was placed on steroids. He was discharged on Wednesday and has both dermatology and an allergy evaluation. The swelling quickly subsided within a couple of days and he was told he had a hypersensitivity immune reaction. Currently he has fully recovered without any residual effects. He has not returned to PT regime other than walking. He never had any problems like this in the past and stated he was a sprint runner during high school. He denies any problems with allergies or previous immunizations  01/14/2008 MR received for hospital DOS 10/15-17/2007 as well as F/u OVs as well as VHC eval 12/7/07. DX: Immune Hypersensitivity Reaction. Pt reported L foot swelling and pain.  Seen in ER and dxd with cellulitis.  Sx worsened despite abx and pt returned to ER 10/15/07 now with areas of erythema, warmth, and increased swelling and pain.  Allergic rxn to vanco in ER. Petechiae noted on feet as well as palmar erythema, and other areas of erythema and rash. R knee pain now noted. No response to abx, steroids started 10/16/07 with good response.  Resolution of sx by F/u 11/1/07.  Assessment: Dermatitis.
Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 75-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Oct2021 at 00:00 (at the age of 75-years-old) as a single dose for COVID-19 immunisation. Medical history included heart bypass. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 01Oct2021, the patient experienced sore arm. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore arm was resolving at the time of this report.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Patient recently had COVID; Patient recently had COVID; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Patient recently had COVID". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Redness, swelling, tenderness, warmth to touch at injection site lasting several days.
Fever; He sweated the whole night; He slept for 24 hours and that is abnormal; This is a spontaneous report from a contactable physician (patient). A 60-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: ELO140; Batch number: 20201221E; Expiration date was not reported) on 21Dec2020 at a single dose, with route of administration unspecified, for COVID-19 immunization. Medical history included previously having COVID-19 from Oct2020 to an unspecified date; abnormal cholesterol; and abnormal blood pressure. Concomitant medications included acyclovir [aciclovir] (ACYCLOVIR); atorvastatin for abnormal cholesterol; hydrochlorothiazide, losartan potassium (LOSARTAN HYDROCHLOROTHIAZIDE ACTAVIS) for abnormal blood pressure; and vitamin D NOS. On 22Dec2020, the patient had fever. In Dec2020, the patient had sweated the whole night; and had slept for 24 hours and that was abnormal. The patient had body temperature values of 101.4 to 101.6 degrees Fahrenheit on 22Dec2020; and 98.8 to 99.9 degrees Fahrenheit on 23Dec2020. The patient had received ibuprofen (MOTRIN) and paracetamol (TYLENOL) as treatment for the fever. The patient considered his adverse reaction "mildish". The outcome of the events was recovered on 22Dec2020 (21:00) for 'fever'; and was recovered in Dec2020 for 'sweated the whole night' and 'slept for 24 hours and that was abnormal'. The reporter's assessment on the causal relationship between the vaccine and the event was related.
Almost immediately there was swelling at the site of the injection followed by fever, lethargy, body aches and irritability which lasted well into the night.  She just went to sleep having the chills.
Vaccine administration error. It is suspected that a ½? needle syringe was used instead of a 1 syringe IM